Clinical Trial

A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Researchers are studying a medicine called MK-8527 to learn how it behaves in the body of healthy adults. The goal of this study is to learn about the effect of MK-8527 when it is taken with food or with other medicines. Researchers also want to learn about the safety of MK-8527 and if people tolerate it. Tolerate means participants will receive treatment in the trial unless they need to stop it due to health problems.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-03
Trial Details
NCT Number NCT07661108
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 44 participants
Start Date 2026-06-30
Primary Completion 2026-10-09 (estimated)
Study Completion 2026-10-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-02